Floatz logo

MELATONIN

Periodontal Diseases

University of BaghdadSmall moleculePhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Periodontal Diseases cohort.

Asset / SponsorPhaseRating
METRONIDAZOLE
Federal University of Rio Grande do Sul
N/AD
Arestin
University of South Carolina
Phase 3NR

Same molecule, other indications

MELATONIN is also rated in:

traumatic brain injuryDormant
BBB
Indicative ·
74 / 100
View asset →
bipolar disorderDormant
BBB
Indicative ·
72 / 100
View asset →
circadian rhythm sleep disorderDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →